Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jae-Weon Kim is a leading figure in gynecologic oncology, whose work has shaped the surgical management of cervical and endometrial cancers. His research centers on optimizing treatment strategies to reduce morbidity without compromising oncologic outcomes. Dr. Kim’s most impactful contribution is his leadership in the landmark SHAPE trial (CCTG CX.5), a phase III study with 26 citations that demonstrated the non-inferiority of simple hysterectomy over radical hysterectomy for low-risk early-stage cervical cancer—a practice-changing finding that spares patients from unnecessary radical surgery. He has also advanced the field through annual "Major clinical research advances" reviews (2007 and 2008), which synthesized key developments such as HPV vaccine efficacy and the role of intensity-modulated radiotherapy. His recent work (2024) comparing minimally invasive versus open staging for non-endometrioid endometrial cancer continues to refine surgical approaches. With over 80 cumulative citations across his top papers, Dr. Kim’s contributions have directly influenced international guidelines and improved patient quality of life. His dedication to collaborative research, exemplified by his role in the Asian Society of Gynecologic Oncology, underscores his commitment to advancing gynecologic cancer care globally.